The CIM-18-S316 Pin Mill from Munson Machinery grinds friable powders, flakes and granules into controlled particle sizes ranging from coarse to fine.
$2.0 million of preferred stock will be purchased upon Synthonics’ achievement of certain milestones, which could be expected during 2016.
Galena Biopharma, Inc. completed enrollment in the NeuVax Phase 3 PRESENT clinical trial. NeuVax is a HER2-directed cancer immunotherapy.
GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH announced the expansion of Rentschler’s biopharmaceutical manufacturing capabilities.
Ventana, a member of the Roche Group, announced it has entered into a master collaboration agreement with Astellas Pharma Inc.
The crackdown comes as similar moves to limit vaccination waivers in the United States have proved to be deeply divisive.
Federal health officials say about 200 people have come down with vomiting and diarrhea aboard two San Diego-bound cruise ships.
A lawyer for Actavis urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.
Union Process, Inc. has manufactured an SD30 dry grinding Attritor for a customer who is using the mill for reactive milling.
The high cost of a drug used to treat Medicaid patients with hepatitis C drew scrutiny from lawmakers earlier this year, but other drugs are also driving up the state's costs and likely will continue to do so for several years, government data reveals.
IDT Australia Limited announced that the U.S. Food and Drug Administration (FDA) has confirmed receipt of the change of ownership letters formally transferring ownership of the 23 generic drug products to IDT.
Cipher Pharmaceuticals Inc. announced it has acquired INNOCUTIS Holdings LLC, a privately held specialty dermatology company, for $45.5 million in cash.
North Dakota's Legislature has passed a measure that gives patients the chance to try experimental drugs that haven't gotten final approval for general use from the U.S. Food and Drug Administration.
The companies said the acquisition creates a top-tiered global OTC pharmaceutical and nutraceutical company.